Skip to main content

HOW CANCER DEVELOPES IN A NORMAL HUMAN BODY ??






Cancer
which is also known as Carcinoma. There are two terms regarding cancer and these are benign and malignant. Benign cancers are not fatal and these can be cured by treatment like surgery and radiotherapy. But malignant cancers are fatal. Because it can not be cured by treatment due to its spreading nature.

At first there are some stimuli that alters the normal function and growing pattern of a cell. The stimuli are called Carcinogens. Carcinogens are chemical or radiation or something like this. When carcinogens enter into the body repeatedly then it alters the normality of our cells. Then our cells show abnormality in growing and metabolism. At the same time our body tries to compensate this changes. But when fails then this abnormality takes figure into any benign lesion. This benign lesion can be the benign cancer cells in an adenoma ( Its a benign tumor of glandular tissue, like breast ) . Then these benign cells grows more rapidly due to repeated stimuli and finally spreads into other organs via blood streams or lymphatics. This is called metastasis. Metastasis can also occur by seeding through body cavities ( IE. Krukenbeg's Tumour of Overy ). Finally this spreader reside in another tissue of our body and further shows abnormality on that organ.

Now, What is the treatment of these things ? The ultimate goal to treat cancer is in two stages. Number one, is it in benign stage or in malignant stage. If its benign then we can treat it with a radiotherapy. Its nothing but a radioactive ray is given to destroy to those abnormal cells. But if its dissiminated through out the body then we will give the Chemotherapy. Its the chemical drugs that selectively destroyes those cancer cells. In benign stage we can also remove that mass of tumour by a surgery.

Comments

Popular posts from this blog

Artificial pancreas ... an option

Coming Soon: 'Artificial Pancreas' Options for Diabetes Miriam E Tucker June 20, 2016   NEW ORLEANS — Nearly closed-loop systems (also referred to as an "artificial pancreas") for improving glycemic control and minimizing hypoglycemia in type 1 diabetes are advancing rapidly, including iterations that deliver insulin alone, insulin with glucagon, or glucagon alone. Findings for several of the products in development demonstrating improvements in glycemic control and reductions in hypoglycemia were presented here at the  American Diabetes Association (ADA) 2016 Scientific Sessions . "Some people may do well on insulin only, while others may need glucagon," Vincent Crabtree, PhD, director of the artificial pancreas program at JDRF, in New York, told  Medscape Medical News , adding, "JDRF would like people to have choice, and we'd like all to be covered [by payers]." The insulin-only hybrid closed-loop 670G system (Medtronic MiniMed) is the...

Overweight and Its Relation to CHD

UNDERSTANDING CORONARY HEART DISEASE (CHD) According to current estimates, 64.4 million Americans have one or more types of cardiovascular disease. Within cardiovascular diseases, coronary heart disease (CHD) is the single largest killer of Americans. CHD caused 502,189 deaths in the US in 2001 – about 1 in every 5. The American Heart Association estimates that 13.2 million Americans have CHD. In fact, up to half of all sudden, out-of-hospital cardiac deaths occur in people with no prior diagnosis of heart disease, and over two-thirds of heart attach sufferers have blockages in their arteries considered to be clinically “insignificant” in terms of plaque burden and percent stenosis. Until recently, it was widely held that most heart attacks were caused by a gradual build-up of atherosclerotic plaque within the arteries of the heart (“hardening of the arteries”), impedes blood flow, and eventually results in blocked blood vessels that can cause acute ischemic events such as...

Protein in human blood platelets points to a new weapon against malaria

One of the world's most devastating diseases is   malaria , responsible for at least a million deaths annually, despite global efforts to combat it. Researchers from the Perelman School of Medicine at the University of Pennsylvania, working with collaborators from Drexel University, The Children's Hospital of Philadelphia, and Johns Hopkins University, have identified a protein in human blood platelets that points to a powerful new weapon against the disease. Their work was published in this months' issue of Cell Host and Microbe. Malaria is caused by parasitic microorganisms of the Plasmodium genus, which infect red blood cells. Recent research at other universities showed that blood platelets can bind to infected red blood cells and kill the parasite, but the exact mechanism was unclear. The investigators on the Cell Host and Microbe paper hypothesized that it might involve host defense peptides (HDP) secreted by the platelets. "We eventually found that a single...